pharma
Solving the drug development problem
February 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, drug discovery, feature, pharma, pistoia alliance
Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …
Vertex doubles Q4 profits, angering cystic fibrosis drug advocates in UK
February 11, 2019Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma
Despite ongoing controversy surrounding the currently stalled negotiations between Vertex and the NHS to make its cystic fibrosis (CF) drug …
UCB teams up with charity to beat treatment-resistant epilepsy in $2.5m partnership
February 11, 2019Research and Development, Sales and Marketing Epilepsy Society, UCB Pharma, epilepsy, pharma
Belgian firm UCB Pharma has announced a new partnership with the charity Epilepsy Society which will see the pair invest …
33% of antibiotics prescribed by NHS are given without associated diagnosis, England’s Chief Medical Officer warns
February 11, 2019Sales and Marketing AMR, Antibiotics, Dame Sally Davies, England, UK, pharma
A third of the antibiotics prescribed by the NHS are given out despite there being no medical evidence that they …
Researchers develop new, more effective method for detection of HIV virus genomes
February 8, 2019Medical Communications, Research and Development HIV, University of Texas, pharma
A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing …
FDA warns over breast implant cancer risk after nine deaths confirmed
February 8, 2019Medical Communications, Research and Development Cancer, FDA, breast implants, pharma
The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine …
J&J to include prices in drug ads on TV
February 8, 2019Medical Communications J&J, JJ, Johnson & Johnson, Trump, pharma, pricing
US multinational Johnson & Johnson has announced that it will include the price of its medicines in TV commercials for …
Eisai and Purdue reveal positive Phase 3 data in insomnia
February 7, 2019Research and Development Eisai, Purdue Pharma, insomnia, lemborexant, pharma
Partners Eisai and Purdue Pharma have lifted the curtain on Phase 3 clinical data on their jointly developed therapy lemborexant …
Pharma chiefs will testify at Senate hearing on rising drug prices
February 7, 2019Sales and Marketing CEO, J&J, JJ, Pfizer, Sanofi, Senate, pharma, pricing
The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …
FDA approves first therapy for acquired thrombotic thrombocytopenic purpura: Sanofi’s Cablivi
February 7, 2019Sales and Marketing Calblivi, FDA, Sanofi, acquired thrombotic thrombocytopenic purpura, pharma
Following swiftly on the heels of the previous success with the announcement of positive Phase 3 data for Icaria in …
NICE joins forces with Canadian peer to offer scientific advice to the pharma industry
February 6, 2019Research and Development, Sales and Marketing CADTH, Canada, NICE, UK, pharma
NICE has announced a collaboration with its Canadian counterpart, the Canadian Agency for Drugs and Technology in Health (CADTH), with …
Sanofi’s Icaria combo extends progression-free survival in multiple myeloma at Phase 3
February 6, 2019Research and Development Icaria, Sanofi, multiple myeloma, pharma
Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …
Former Ablynx exec joins Kiadis as Chief Scientific Officer
February 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, appointment, kiadis, pharma
Dutch/US firm Kiadis Pharma revealed that Dr Robert Friesen became its new Chief Science Officer (CSO) as January turned into …
Lilly’s Olumiant impresses in twin Phase 3 atopic dermatitis trials
February 5, 2019Manufacturing and Production, Research and Development Eli Lilly, Olumiant, atopic dermatitis, pharma
Eli Lilly has unveiled new Phase 3 data from two studies into the oral Janus kinase (JAK) inhibitor Olumiant (baricitinib). …
AstraZeneca scores accelerated approval in US and Europe for respiratory syncytial virus drug
February 5, 2019Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, EMA, FDA, MEDI8897, pharma, respiratory syncytial virus
It’s a double victory for AstraZeneca as the company announced its F monoclonal antibody MEDI8897 has been granted accelerated review …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
